Skip to main content
Clinical Trials/EUCTR2014-001488-11-SE
EUCTR2014-001488-11-SEActive, not recruitingNot Applicable

Effects of expectations, medication and placebo on objective and self-rated performance during the Quantified Behavior Test in terms of the ADHD core signs hyperactivity, inattention and impulsivity in patients with untreated ADHD and Substance Use Disorder

andstinget Västmanland0 sitesStarted: December 16, 2014Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. 18 years old or older.
  • 2. ADHD is diagnosed according to DSM-5 criteria.
  • 3. Substance use disorder is diagnosed according to DSM-5 criteria.
  • 4. Qb-score 1.3 or higher on any of the weighted summary parameters QbActivity, QbInAttention or QbImpulsivity on the
  • 5. Patients are given their written informed consent to participate in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • 1. Affected by alcohol or drugs during the last month.
  • 2. Untreted severe comorbid psychiatric or somatic illness.
  • 3. Bloodpressure 150/95 or higher.
  • 4. Irregular pulse, or pulse 100 or higher.
  • 5. No counter indications according to the Medikinet pill.
  • 6. Concurrent clinical diagnossi that significantly could affect test performance.
  • 7. Concurrent prescription medicines for ADHD or medicines that significantly could affect test performance.

Investigators

Sponsor
andstinget Västmanland

Similar Trials